NLGIA
BIIB icon

Nippon Life Global Investors Americas’s Biogen BIIB Stock Holding History

Nippon Life Global Investors Americas’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.6M Buy
137,220
+103,650
+309% +$19.8M 1.18% 27
2026
Q1 		$6.15M Buy
33,570
+7,080
+27% +$1.3M 0.28% 60
2025
Q4 		$4.66M Buy
+26,490
New +$4.33M 0.19% 63
2024
Q1 		– Sell
-6,630
Closed -$1.72M – 106
2023
Q4 		$1.72M Hold
6,630
– – 0.1% 93
2023
Q3 		$1.7M Buy
+6,630
New +$1.77M 0.1% 96
2021
Q4 		– Sell
-10,890
Closed -$3.08M – 151
2021
Q3 		$3.08M Sell
10,890
-1,520
-12% -$498K 0.16% 113
2021
Q2 		$4.3M Buy
+12,410
New +$3.76M 0.21% 106
2019
Q4 		– Sell
-14,610
Closed -$3.4M – 144
2019
Q3 		$3.4M Hold
14,610
– – 0.25% 97
2019
Q2 		$3.42M Buy
14,610
+1,600
+12% +$369K 0.26% 96
2019
Q1 		$3.08M Hold
13,010
– – 0.25% 104
2018
Q4 		$3.92M Buy
+13,010
New +$4.15M 0.34% 82
2018
Q1 		– Sell
-30,900
Closed -$9.84M – 150
2017
Q4 		$9.84M Buy
30,900
+3,230
+12% +$1.04M 0.78% 47
2017
Q3 		$8.66M Buy
27,670
+4,100
+17% +$1.21M 0.74% 48
2017
Q2 		$6.4M Hold
23,570
– – 0.55% 60
2017
Q1 		$6.44M Buy
23,570
+3,830
+19% +$1.08M 0.57% 61
2016
Q4 		$5.6M Hold
19,740
– – 0.52% 71
2016
Q3 		$6.18M Sell
19,740
-4,980
-20% -$1.47M 0.58% 61
2016
Q2 		$5.98M Sell
24,720
-950
-4% -$250K 0.57% 67
2016
Q1 		$6.68M Sell
25,670
-710
-3% -$188K 0.63% 59
2015
Q4 		$8.08M Buy
26,380
+4,780
+22% +$1.37M 0.76% 50
2015
Q3 		$6.3M Buy
21,600
+780
+4% +$258K 0.63% 63
2015
Q2 		$8.41M Buy
20,820
+13,420
+181% +$5.39M 0.76% 51
2015
Q1 		$3.13M Sell
7,400
-290
-4% -$114K 0.29% 102
2014
Q4 		$2.61M Buy
7,690
+920
+14% +$298K 0.24% 117
2014
Q3 		$2.24M Buy
+6,770
New +$2.23M 0.21% 125

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Nippon Life Global Investors Americas's BIIB Position: Q2 2026 in Review

Nippon Life Global Investors Americas increased its Biogen (BIIB) stake by 309% in Q2 2026, buying an estimated $19.8M and bringing the position to 137,220 shares worth $29.6M. The position accounts for 1.18% of the portfolio, ranked #27.

Nippon Life Global Investors Americas first reported a position in BIIB in Q3 2014 and has held it in 25 quarters since. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Nippon Life Global Investors Americas held 137,220 shares of Biogen worth $29.6M as of Q2 2026.
  • Nippon Life Global Investors Americas bought 103,650 Biogen shares in Q2 2026, an estimated $19.8M.
  • Biogen made up 1.18% of Nippon Life Global Investors Americas's portfolio in Q2 2026, its #27 holding.
  • Nippon Life Global Investors Americas first reported a position in Biogen in Q3 2014 and has held it in 25 quarters since.
  • 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Nippon Life Global Investors Americas's 13F filing for Q2 2026, filed 6 Aug 2026.